Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Diarrhea × 30 days × Clear all

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 56 Neoplasms 52 Carcinoma, Non-Small-Cell Lung 45 Lung Neoplasms 33 Prostatic Neoplasms 31 Leukemia, Myeloid, Acute 27 Colorectal Neoplasms 27 Multiple Myeloma 19 Glioma 18 Squamous Cell Carcinoma of Head and Neck 17 Brain Neoplasms 16 Ovarian Neoplasms 15 Glioblastoma 14 Carcinoma, Hepatocellular 14 Recurrence 13 Pancreatic Neoplasms 13 Neoplasm Metastasis 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Small Cell Lung Carcinoma 11 Uterine Cervical Neoplasms 10 Urinary Bladder Neoplasms 10 Triple Negative Breast Neoplasms 9 Melanoma 9 Head and Neck Neoplasms 9 Endometrial Neoplasms 9 Carcinoma, Renal Cell 9 Stomach Neoplasms 7 Sarcoma 7 Rectal Neoplasms 7 Hematologic Neoplasms 7

Interventions

ceterizine hydrochloride 1 capivasertib 1 Loperamide 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07426822 2026-02-24

SAFE-CAP

Yale University

Phase 2 Not yet recruiting

Diarrhea, Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡